跳至主要内容
临床试验/CTRI/2024/02/062387
CTRI/2024/02/062387招募中3 期

Parasitic Ulcer Treatment Trial (PUTT)

National Institute of Health-National Eye Institute1 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2024年6月1日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
232
试验地点
1
主要终点
Improved 6 month best corrected visual acuity and hasten the time for acanthamoeba keratitis clinical resolution in the steroid group

研究概览

简要总结

Acanthamoeba Keratitis (AK) is an extremely painful, blinding infection requiring long treatment courses. In India, higher incidence of AK has been observed among farmers. Most common mode of injury is mud and contaminated water exposure. The best way to treat AK is entirely unclear. Even with successful antiamoebic treatment, many eyes develop corneal inflammation leading to corneal scarring and poor vision. Use of topical corticosteroids for the treatment of AK is unclear. In this proposal we seek to establish the safety and efficacy of topical corticosteroids when used alongside anti-amoebic agents and to determine whether any host or pathogen factors can be used to predict the clinical response to steroid therapy by doing Metagenomic deep sequencing (MDS). Aravind Eye Hospital, Madurai, and Proctor Foundation, University of California-San Fransisco, will work in collaboration to better understand these mechanisms and help improve the outcomes of AK patients in the future.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • a) Smear culture PCR Confocal positive Acanthamoeba keratitis b) Acanthamoeba keratitis patients treated with antiamoebic therapy and have corneal episcleral or anterior chamber inflammation at 4 weeks c) Appropriate written and informed consent.

排除标准

  • a) No consent b) Fungal or Herpetic keratitis c) Corneal perforation and impending corneal perforation d) Prior keratoplasty e) Visual acuity of No light perception in the affected eye f) Debilitated patient g) Patients on systemic corticosteroids h) Corticosteroids allergy i) Pregnant mothers j) Steroids responders.

结局指标

主要结局

Improved 6 month best corrected visual acuity and hasten the time for acanthamoeba keratitis clinical resolution in the steroid group

时间窗: 4 years

次要结局

  • To study the contribution of organism virulence factors and host factors for severe inflammatory outcomes by metagenomic deep sequencing(4 years)

研究者

发起方
National Institute of Health-National Eye Institute
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr N Venkatesh Prajna

Aravind Eye Hospital and Postgraduate Institute of Ophthalmology

研究点 (1)

Loading locations...

相似试验